Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Stem Cell Research

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 112 articles:
HTML format
Text format



Single Articles


    January 2020
  1. KEYSAR SB, Gomes N, Miller B, Jackson BC, et al
    Inhibiting translation elongation with SVC112 suppresses cancer stem cells and inhibits growth in head and neck squamous carcinoma.
    Cancer Res. 2020 Jan 7. pii: 0008-5472.CAN-19-3232.
    PubMed     Text format     Abstract available


    November 2019
  2. SACHS K, Sarver AL, Noble-Orcutt KE, LaRue RS, et al
    Single-cell gene expression analyses reveal distinct self-renewing and proliferating subsets in the leukemia stem cell compartment in acute myeloid leukemia.
    Cancer Res. 2019 Nov 29. pii: 0008-5472.CAN-18-2932.
    PubMed     Text format     Abstract available


  3. KONDO T, Ando M, Nagai N, Tomisato W, et al
    The NOTCH-FOXM1 Axis Plays a Key Role in Mitochondrial Biogenesis in the Induction of Human Stem Cell Memory-like CAR-T Cells.
    Cancer Res. 2019 Nov 25. pii: 0008-5472.CAN-19-1196.
    PubMed     Text format     Abstract available


  4. LI C, Course MM, McNeish IA, Drescher CW, et al
    Prophylactic in vivo hematopoietic stem cell gene therapy with an immune checkpoint inhibitor reverses tumor growth in syngeneic mouse tumor models.
    Cancer Res. 2019 Nov 14. pii: 0008-5472.CAN-19-1044.
    PubMed     Text format     Abstract available


  5. MARTIN ML, Adileh M, Hsu KS, Hua G, et al
    Organoids reveal that inherent radiosensitivity of small and large intestinal stem cells determines organ sensitivity.
    Cancer Res. 2019 Nov 5. pii: 0008-5472.CAN-19-0312.
    PubMed     Text format     Abstract available


    October 2019
  6. LIBBY CJ, McConathy J, Darley-Usmar V, Hjelmeland AB, et al
    The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology.
    Cancer Res. 2019 Oct 1. pii: 0008-5472.CAN-19-1169.
    PubMed     Text format     Abstract available


    September 2019
  7. LY M, Rentas S, Vujovic A, Wong N, et al
    Diminished AHR signaling drives human acute myeloid leukemia stem cell maintenance.
    Cancer Res. 2019 Sep 13. pii: 0008-5472.CAN-19-0274.
    PubMed     Text format     Abstract available


    August 2019
  8. MUKOHYAMA J, Isobe T, Hu Q, Hayashi T, et al
    miR-221 targets QKI to enhance the tumorigenic capacity of human colorectal cancer stem cells.
    Cancer Res. 2019 Aug 15. pii: 0008-5472.CAN-18-3544.
    PubMed     Text format     Abstract available


    July 2019
  9. YE S, Ding YF, Jia WH, Liu XL, et al
    SET domain-containing protein 4 epigenetically controls breast cancer stem cell quiescence.
    Cancer Res. 2019 Jul 15. pii: 0008-5472.CAN-19-1084.
    PubMed     Text format     Abstract available


  10. YOON AR, Hong J, Li Y, Shin HC, et al
    Mesenchymal stem cell-mediated delivery of an oncolytic adenovirus enhances antitumor efficacy in hepatocellular carcinoma.
    Cancer Res. 2019 Jul 9. pii: 0008-5472.CAN-18-3900.
    PubMed     Text format     Abstract available


  11. DAS B, Pal B, Bhuyan R, Li H, et al
    MYC regulates the HIF-2alpha stemness pathway via Nanog and Sox2 to maintain self-renewal in cancer stem cells versus non-stem cancer cells.
    Cancer Res. 2019 Jul 2. pii: 0008-5472.CAN-18-2847.
    PubMed     Text format     Abstract available


    May 2019
  12. BOISE LH, Shanmugam M
    Stromal Support of Metabolic Function through Mitochondrial Transfer in Multiple Myeloma.
    Cancer Res. 2019;79:2102-2103.
    PubMed     Text format     Abstract available


    April 2019
  13. SHIDAL C, Singh NP, Nagarkatti P, Nagarkatti M, et al
    MicroRNA-92 expression in CD133+ melanoma stem cells regulates immunosuppression in the tumor microenvironment via integrin-dependent activation of TGF-beta.
    Cancer Res. 2019 Apr 23. pii: 0008-5472.CAN-18-2659.
    PubMed     Text format     Abstract available


  14. COLOMBO MP, Lecis D
    When Failure Is Worse Than Giving Up: The Case of CTL.
    Cancer Res. 2019;79:1753-1755.
    PubMed     Text format     Abstract available


  15. WANG D, Li W, Zhao R, Chen L, et al
    Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate H3K56 for the Treatment of Cancer Stem-Like Cells In Vivo.
    Cancer Res. 2019;79:1769-1783.
    PubMed     Text format     Abstract available


  16. BUSHNELL GG, Hardas TP, Hartfield RM, Zhang Y, et al
    Biomaterial Scaffolds Recruit an Aggressive Population of Metastatic Tumor Cells In Vivo.
    Cancer Res. 2019;79:2042-2053.
    PubMed     Text format     Abstract available


  17. DANG N, Lin Y, Rutgeerts O, Sagaert X, et al
    Solid tumor-induced immune regulation alters the GvHD/GvT paradigm after allogenic bone marrow transplantation.
    Cancer Res. 2019 Apr 1. pii: 0008-5472.CAN-18-3143.
    PubMed     Text format     Abstract available


    March 2019
  18. SRIVASTAVA AK, Banerjee A, Cui T, Han C, et al
    Inhibition of miR-328-3p impairs cancer stem cell function and prevents metastasis in ovarian cancer.
    Cancer Res. 2019 Mar 20. pii: 0008-5472.CAN-18-3668.
    PubMed     Text format     Abstract available


  19. LIU C, Banister CE, Buckhaults PJ
    Spindle assembly checkpoint inhibition can resensitize p53-null stem cells to cancer chemotherapy.
    Cancer Res. 2019 Mar 12. pii: 0008-5472.CAN-18-3024.
    PubMed     Text format     Abstract available


  20. TAO R, Murad N, Xu Z, Zhang P, et al
    MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells.
    Cancer Res. 2019 Mar 12. pii: 0008-5472.CAN-18-1787.
    PubMed     Text format     Abstract available


  21. FEKIR K, Dubois-Pot-Schneider H, Desert R, Daniel Y, et al
    Retrodifferentiation of human tumor hepatocytes to stem cells leads to metabolic reprogramming and chemoresistance.
    Cancer Res. 2019 Mar 5. pii: 0008-5472.CAN-18-2110.
    PubMed     Text format     Abstract available


  22. BECKMANN PJ, Larson JD, Larsson AT, Ostergaard JP, et al
    Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors.
    Cancer Res. 2019;79:905-917.
    PubMed     Text format     Abstract available


    February 2019
  23. BHOLA NE, Jansen VM, Koch JP, Li H, et al
    Correction: Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population.
    Cancer Res. 2019;79:875.
    PubMed     Text format    


  24. TAKEDA M, Koseki J, Takahashi H, Miyoshi N, et al
    Disruption of endolysosomal RAB5/7 efficiently eliminates colorectal cancer stem cells.
    Cancer Res. 2019 Feb 14. pii: 0008-5472.CAN-18-2192.
    PubMed     Text format     Abstract available


    January 2019
  25. STEIN RG, Ebert S, Schlahsa L, Scholz CJ, et al
    Cognate Non-Lytic Interactions between CD8+ T cells and Breast Cancer Cells Induce Cancer Stem Cell-like Properties.
    Cancer Res. 2019 Jan 28. pii: 0008-5472.CAN-18-0387.
    PubMed     Text format     Abstract available


  26. PARK HK, Hong JH, Oh YT, Kim SS, et al
    Interplay between TRAP1 and sirtuin-3 modulates mitochondrial respiration and oxidative stress to maintain stemness of glioma stem cells.
    Cancer Res. 2019 Jan 25. pii: 0008-5472.CAN-18-2558.
    PubMed     Text format     Abstract available


  27. CARTER BZ, Mak PY, Wang X, Tao W, et al
    An ARC-regulated IL1beta/Cox-2/PGE2/beta-catenin/ARC circuit controls leukemia-microenvironment interactions and confers drug resistance in AML.
    Cancer Res. 2019 Jan 23. pii: 0008-5472.CAN-18-0921.
    PubMed     Text format     Abstract available


  28. SUN T, Patil R, Galstyan A, Klymyshyn D, et al
    Blockade of a laminin-411 - Notch axis with CRISPR/Cas9 or a nanobioconjugate inhibits glioblastoma growth through tumor-microenvironment crosstalk.
    Cancer Res. 2019 Jan 18. pii: 0008-5472.CAN-18-2725.
    PubMed     Text format     Abstract available


  29. AL SAYED MF, Amrein MA, Buhrer ED, Huguenin AL, et al
    T-cell-Secreted TNFalpha Induces Emergency Myelopoiesis and Myeloid-Derived Suppressor Cell Differentiation in Cancer.
    Cancer Res. 2019;79:346-359.
    PubMed     Text format     Abstract available


  30. VUMMIDI GIRIDHAR P, Williams K, VonHandorf AP, Deford PL, et al
    Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity.
    Cancer Res. 2019 Jan 9. pii: 0008-5472.CAN-18-1753.
    PubMed     Text format     Abstract available


  31. OLIPHANT MUJ, Vincent MY, Galbraith MD, Pandey A, et al
    Six2 mediates late-stage metastasis via direct regulation of Sox2 and induction of a cancer stem cell program.
    Cancer Res. 2019 Jan 3. pii: 0008-5472.CAN-18-1791.
    PubMed     Text format     Abstract available


  32. HU T, Chong Y, Lu S, Qin H, et al
    Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis in Mice.
    Cancer Res. 2019;79:114-124.
    PubMed     Text format     Abstract available


    December 2018
  33. GU Y, Wei X, Sun Y, Gao H, et al
    miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features.
    Cancer Res. 2018 Dec 7. pii: 0008-5472.CAN-18-1675.
    PubMed     Text format     Abstract available


  34. WARDA W, Larosa F, Neto Da Rocha M, Trad R, et al
    CML hematopoietic stem cells expressing IL-1RAP can be targeted by chimeric antigen receptor (CAR)-engineered T cells.
    Cancer Res. 2018 Dec 4. pii: 0008-5472.CAN-18-1078.
    PubMed     Text format     Abstract available


    November 2018
  35. BU W, Liu Z, Jiang W, Nagi C, et al
    Mammary precancerous stem and non-stem cells evolve into cancers of distinct subtypes.
    Cancer Res. 2018 Nov 6. pii: 0008-5472.CAN-18-1087.
    PubMed     Text format     Abstract available


    October 2018
  36. CHOI M, Yu SJ, Choi Y, Lee HR, et al
    Polymer thin film-induced tumor spheroids acquire cancer stem cell-like properties.
    Cancer Res. 2018 Oct 23. pii: 0008-5472.CAN-18-0927.
    PubMed     Text format     Abstract available


  37. LIU T, Xu H, Huang M, Ma W, et al
    Circulating glioma cells exhibit stem cell-like properties.
    Cancer Res. 2018 Oct 15. pii: 0008-5472.CAN-18-0650.
    PubMed     Text format     Abstract available


  38. RAVINDRAN MENON D, Luo Y, Arcaroli JJ, Liu S, et al
    CDK1 interacts with Sox2 and promotes tumor initiation in human melanoma.
    Cancer Res. 2018 Oct 8. pii: 0008-5472.CAN-18-0330.
    PubMed     Text format     Abstract available


    September 2018
  39. VAN LIDTH DE JEUDE JF, Spaan CN, Meijer BJ, Smit WL, et al
    Heterozygosity of chaperone Grp78 reduces intestinal stem cell regeneration potential and protects against adenoma formation.
    Cancer Res. 2018 Sep 19. pii: 0008-5472.CAN-17-3600.
    PubMed     Text format     Abstract available


  40. CHEN C, Okita Y, Watanabe Y, Abe F, et al
    Glycoprotein nmb is exposed on the surface of dormant breast cancer cells and induces stem cell-like properties.
    Cancer Res. 2018 Sep 17. pii: 0008-5472.CAN-18-0599.
    PubMed     Text format     Abstract available


    August 2018
  41. KOIFMAN G, Shetzer Y, Eizenberger S, Solomon H, et al
    A mutant p53-dependent embryonic stem cell gene signature is associated with augmented tumorigenesis of stem cells.
    Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-0805.
    PubMed     Text format     Abstract available


  42. HOGSTROM J, Heino S, Kallio P, Lahde M, et al
    Transcription factor PROX1 suppresses Notch pathway activation via the nucleosome remodeling and deacetylase complex in colorectal cancer stem-like cells.
    Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-0451.
    PubMed     Text format     Abstract available


  43. HILLER B, Hoppe A, Haase C, Hiller C, et al
    Ribonucleotide excision repair is essential to prevent squamous cell carcinoma of the skin.
    Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-1099.
    PubMed     Text format     Abstract available


  44. BAYLEY R, Blakemore D, Cancian L, Dumon S, et al
    MYBL2 supports DNA double strand break repair in haematopoietic stem cells.
    Cancer Res. 2018 Aug 6. pii: 0008-5472.CAN-18-0273.
    PubMed     Text format     Abstract available


    July 2018
  45. UBELLACKER JM, Baryawno N, Severe N, DeCristo MJ, et al
    Modulating bone marrow hematopoietic lineage potential to prevent bone metastasis in breast cancer.
    Cancer Res. 2018 Jul 31. pii: 0008-5472.CAN-18-0548.
    PubMed     Text format     Abstract available


  46. CARRUTHERS RD, Ahmed SU, Ramachandran S, Strathdee K, et al
    Replication stress drives constitutive activation of the DNA damage response and radioresistance in glioblastoma stem-like cells.
    Cancer Res. 2018 Jul 5. pii: 0008-5472.CAN-18-0569.
    PubMed     Text format     Abstract available


    June 2018
  47. QAZI MA, Vora P, Venugopal C, Adams J, et al
    Co-targeting ephrin receptor tyrosine kinases A2 and A3 in cancer stem cells reduces growth of recurrent glioblastoma.
    Cancer Res. 2018 Jun 26. pii: 0008-5472.CAN-18-0267.
    PubMed     Text format     Abstract available


  48. HIRST J, Pathak HB, Hyter S, Pessetto ZY, et al
    Licofelone enhances the efficacy of paclitaxel in ovarian cancer by reversing drug resistance and tumor stem-like properties.
    Cancer Res. 2018 Jun 11. pii: 0008-5472.CAN-17-3993.
    PubMed     Text format     Abstract available


  49. LU H, Tran L, Park Y, Chen I, et al
    Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF-1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment.
    Cancer Res. 2018 Jun 7. pii: 0008-5472.CAN-18-0270.
    PubMed     Text format     Abstract available


    May 2018
  50. ULLMANN P, Rodriguez F, Schmitz M, Meurer SK, et al
    The microRNA-371~373 cluster represses colon cancer initiation and metastatic colonization by inhibiting the TGFBR2/ID1 signaling axis.
    Cancer Res. 2018 May 10. pii: 0008-5472.CAN-17-3003.
    PubMed     Text format     Abstract available


  51. MATSUNAGA N, Ogino T, Hara Y, Tanaka T, et al
    Optimized dosing schedule based on circadian dynamics of mouse breast cancer stem cells improves the anti-tumor effects of aldehyde dehydrogenase.
    Cancer Res. 2018 May 7. pii: 0008-5472.CAN-17-4034.
    PubMed     Text format     Abstract available


  52. HU T, Chong Y, Lu S, Wang R, et al
    MicroRNA 339 promotes development of Stem Cell Leukemia/Lymphoma syndrome via downregulation of the BCL2L11 and BAX pro-apoptotic genes.
    Cancer Res. 2018 May 7. pii: 0008-5472.CAN-17-4049.
    PubMed     Text format     Abstract available


    April 2018
  53. KAID C, Goulart E, Caires-Junior LC, Araujo BHS, et al
    Zika virus selectively kills aggressive human embryonal CNS tumor cells in vitro and in vivo.
    Cancer Res. 2018 Apr 26. pii: 0008-5472.CAN-17-3201.
    PubMed     Text format     Abstract available


  54. RESAR L, Chia L, Xian L
    Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.
    Cancer Res. 2018 Apr 4. pii: 0008-5472.CAN-17-3045.
    PubMed     Text format     Abstract available


  55. KIKUCHI J, Kuroda Y, Koyama D, Osada N, et al
    Myeloma Cells Are Activated in Bone Marrow Microenvironment by the CD180/MD-1 Complex, Which Senses Lipopolysaccharide.
    Cancer Res. 2018;78:1766-1778.
    PubMed     Text format     Abstract available


  56. SHEA MP, O'Leary KA, Fakhraldeen SA, Goffin V, et al
    Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ERalpha(+) Mammary Carcinomas.
    Cancer Res. 2018;78:1672-1684.
    PubMed     Text format     Abstract available


    March 2018
  57. REN D, Zhu X, Kong R, Zhao Z, et al
    Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer.
    Cancer Res. 2018 Mar 22. pii: 0008-5472.CAN-17-2994.
    PubMed     Text format     Abstract available


  58. HALL AW, Battenhouse AM, Shivram H, Morris AR, et al
    Bivalent chromatin domains in glioblastoma reveal a subtype-specific signature of glioma stem cells.
    Cancer Res. 2018 Mar 16. pii: 0008-5472.CAN-17-1724.
    PubMed     Text format     Abstract available


  59. CONDELLO S, Sima LE, Ivan C, Cardenas H, et al
    Tissue transglutaminase regulates interactions between ovarian cancer stem cells and the tumor niche.
    Cancer Res. 2018 Mar 6. pii: 0008-5472.CAN-17-2319.
    PubMed     Text format     Abstract available


  60. PAQUET-FIFIELD S, Koh SL, Cheng L, Beyit LM, et al
    Tight junction protein claudin-2 promotes self-renewal of human colorectal cancer stem-like cells.
    Cancer Res. 2018 Mar 6. pii: 0008-5472.CAN-17-1869.
    PubMed     Text format     Abstract available


  61. WANG H, Shepard MJ, Zhang C, Dong L, et al
    Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina.
    Cancer Res. 2018;78:1266-1274.
    PubMed     Text format     Abstract available


    February 2018
  62. SORRENTINO C, Ciummo SL, Cipollone G, Caputo S, et al
    Interleukin-30/IL-27p28 shapes prostate cancer stem-like cell behavior and is critical for tumor onset and metastasization.
    Cancer Res. 2018 Feb 27. pii: 0008-5472.CAN-17-3117.
    PubMed     Text format     Abstract available


  63. CHENG BY, Lau EY, Leung HW, Leung CO, et al
    IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-2445.
    PubMed     Text format     Abstract available


  64. RIMKUS TK, Carpenter RL, Sirkisoon SR, Zhu D, et al
    Truncated glioma-associated oncogene homolog 1 (tGLI1) mediates mesenchymal glioblastoma via transcriptional activation of CD44.
    Cancer Res. 2018 Feb 20. pii: 0008-5472.CAN-17-2933.
    PubMed     Text format     Abstract available


  65. LIU C, Liu L, Chen X, Cheng J, et al
    LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells.
    Cancer Res. 2018;78:938-949.
    PubMed     Text format     Abstract available


  66. DE S, Lindner DJ, Coleman C, Wildey G, et al
    The FACT inhibitor CBL0137 synergizes with cisplatin in small cell lung cancer by increasing NOTCH1 expression and targeting tumor-initiating cells.
    Cancer Res. 2018 Feb 13. pii: 0008-5472.CAN-17-1920.
    PubMed     Text format     Abstract available


  67. JUNG Y, Cackowski FC, Yumoto K, Decker A, et al
    CXCL12gamma Promotes Development of Metastatic Castration Resistant Prostate Cancer by Induction of Cancer Stem Cell and Neuroendocrine Phenotypes.
    Cancer Res. 2018 Feb 5. pii: 0008-5472.CAN-17-2332.
    PubMed     Text format     Abstract available


    January 2018
  68. SANG Y, Li Y, Song L, Alvarez AA, et al
    TRIM59 promotes gliomagenesis by inhibiting TC45 dephosphorylation of STAT3.
    Cancer Res. 2018 Jan 31. pii: 0008-5472.CAN-17-2774.
    PubMed     Text format     Abstract available


  69. YAN TT, Ren LL, Shen CQ, Wang ZH, et al
    MicroRNA-508 defines the stem-like/mesenchymal subtype in colorectal cancer.
    Cancer Res. 2018 Jan 26. pii: 0008-5472.CAN-17-2101.
    PubMed     Text format     Abstract available


  70. JIAO X, Velasco-Velazquez MA, Wang M, Li Z, et al
    CCR5 governs DNA damage and breast cancer stem cell expansion.
    Cancer Res. 2018 Jan 22. pii: 0008-5472.CAN-17-0915.
    PubMed     Text format     Abstract available


  71. YANG Y, Leonard M, Zhang Y, Zhao D, et al
    HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1.
    Cancer Res. 2018;78:422-435.
    PubMed     Text format     Abstract available


  72. LIU C, Nie D, Li J, Du X, et al
    Antitumor effects of blocking protein neddylation in T315I-BCR-ABL leukemia cells and leukemia stem cells.
    Cancer Res. 2018 Jan 10. pii: 0008-5472.CAN-17-1733.
    PubMed     Text format     Abstract available


  73. TIMANER M, Letko-Khait N, Kotsofruk R, Benguigui M, et al
    Therapy-educated mesenchymal stem cells enrich for tumor initiating cells.
    Cancer Res. 2018 Jan 4. pii: 0008-5472.CAN-17-1547.
    PubMed     Text format     Abstract available


  74. CARAMEL J, Ligier M, Puisieux A
    Pleiotropic Roles for ZEB1 in Cancer.
    Cancer Res. 2018;78:30-35.
    PubMed     Text format     Abstract available


  75. OOKI A, Del Carmen Rodriguez Pena M, Marchionni L, Dinalankara W, et al
    YAP1 and COX2 Coordinately Regulate Urothelial Cancer Stem-like Cells.
    Cancer Res. 2018;78:168-181.
    PubMed     Text format     Abstract available


  76. ROSSNAGL S, Ghura H, Groth C, Altrock E, et al
    A Subpopulation of Stromal Cells Controls Cancer Cell Homing to the Bone Marrow.
    Cancer Res. 2018;78:129-142.
    PubMed     Text format     Abstract available


    December 2017
  77. MAEDA T, Hiraki M, Jin C, Rajabi H, et al
    MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer.
    Cancer Res. 2017 Dec 20. pii: 0008-5472.CAN-17-1636.
    PubMed     Text format     Abstract available


  78. BROCK A, Huang S
    Precision Oncology: Between Vaguely Right and Precisely Wrong.
    Cancer Res. 2017;77:6473-6479.
    PubMed     Text format     Abstract available


    November 2017
  79. HOU P, Li L, Chen F, Chen Y, et al
    PTBP3-mediated regulation of ZEB1 mRNA stability promotes epithelial-mesenchymal transition in breast cancer.
    Cancer Res. 2017 Nov 29. pii: 0008-5472.CAN-17-0883.
    PubMed     Text format     Abstract available


  80. HUANG WY, Lai SF, Chiu HY, Chang M, et al
    Mobilizing Transit-Amplifying Cell-Derived Ectopic Progenitors Prevents Hair Loss from Chemotherapy or Radiation Therapy.
    Cancer Res. 2017;77:6083-6096.
    PubMed     Text format     Abstract available


  81. CHIBA Y, Mizoguchi I, Furusawa J, Hasegawa H, et al
    Interleukin-27 Exerts Its Antitumor Effects by Promoting Differentiation of Hematopoietic Stem Cells to M1 Macrophages.
    Cancer Res. 2017 Nov 1. pii: canres.0960.2017.
    PubMed     Text format     Abstract available


  82. SERVIDEI T, Meco D, Muto V, Bruselles A, et al
    Novel SEC61G-EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens.
    Cancer Res. 2017;77:5860-5872.
    PubMed     Text format     Abstract available


  83. ISHIGAKI H, Maeda T, Inoue H, Akagi T, et al
    Transplantation of iPS-Derived Tumor Cells with a Homozygous MHC Haplotype Induces GRP94 Antibody Production in MHC-Matched Macaques.
    Cancer Res. 2017;77:6001-6010.
    PubMed     Text format     Abstract available


    October 2017
  84. HOUSE CD, Jordan E, Hernandez L, Ozaki M, et al
    NF-kB promotes ovarian tumorigenesis via classical pathways supporting proliferative cancer cells and alternative pathways supporting ALDH+ cancer stem-like cells.
    Cancer Res. 2017 Oct 26. pii: canres.0366.2017.
    PubMed     Text format     Abstract available


  85. LI Y, Zhong C, Liu D, Yu W, et al
    Evidence for Kaposi's Sarcoma originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition.
    Cancer Res. 2017 Oct 24. pii: canres.1961.2017.
    PubMed     Text format     Abstract available


    September 2017
  86. ISHIHARA S, Inman DR, Li WJ, Ponik SM, et al
    Mechano-signal transduction in mesenchymal stem cells induces prosaposin secretion to drive the proliferation of breast cancer cells.
    Cancer Res. 2017 Sep 28. pii: canres.0569.2017.
    PubMed     Text format     Abstract available


  87. DE GRANDIS M, Bardin F, Fauriat C, Zemmour C, et al
    JAM-C identifies Src family kinase-activated leukemia-initiating cells and predicts poor prognosis in acute myeloid leukemia.
    Cancer Res. 2017 Sep 28. pii: canres.1223.2017.
    PubMed     Text format     Abstract available


  88. KIDDER BL, He R, Wangsa D, Padilla-Nash HM, et al
    SMYD5 controls heterochromatin and chromosome integrity during embryonic stem cell differentiation.
    Cancer Res. 2017 Sep 26. pii: canres.0828.2017.
    PubMed     Text format     Abstract available


  89. MATSUMOTO T, Takai A, Eso Y, Kinoshita K, et al
    Proliferating EpCAM-positive ductal cells in the inflamed liver give rise to hepatocellular carcinoma.
    Cancer Res. 2017 Sep 26. pii: canres.1800.2017.
    PubMed     Text format     Abstract available


  90. YANG A, Qin S, Schulte BA, Ethier SP, et al
    MYC Inhibition depletes cancer stem-like cells in triple-negative breast cancer.
    Cancer Res. 2017 Sep 26. pii: canres.3452.2016.
    PubMed     Text format     Abstract available


  91. YAN X, Zhang D, Wu W, Wu S, et al
    Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and miR-34a.
    Cancer Res. 2017 Sep 25. pii: canres.1915.2017.
    PubMed     Text format     Abstract available


  92. YANG R, Chen LH, Hansen LJ, Carpenter AB, et al
    Cic loss promotes gliomagenesis via aberrant neural stem cell proliferation and differentiation.
    Cancer Res. 2017 Sep 22. pii: canres.1018.2017.
    PubMed     Text format     Abstract available


  93. SHUKLA V, Rao M, Zhang H, Beers J, et al
    ASXL3 is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.
    Cancer Res. 2017 Sep 21. pii: canres.0570.2017.
    PubMed     Text format     Abstract available


  94. DASHZEVEG NK, Taftaf R, Ramos EK, Torre-Healy L, et al
    New Advances and Challenges of Targeting Cancer Stem Cells.
    Cancer Res. 2017 Sep 19. doi: 10.1158/0008-5472.CAN-17-0054.
    PubMed     Text format     Abstract available


  95. SONG KH, Choi CH, Lee HJ, Oh SJ, et al
    HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells.
    Cancer Res. 2017;77:5039-5053.
    PubMed     Text format     Abstract available


  96. BORRIELLO L, Nakata R, Sheard MA, Fernandez GE, et al
    Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells.
    Cancer Res. 2017;77:5142-5157.
    PubMed     Text format     Abstract available


  97. BHAGAT TD, Chen S, Bartenstein M, Barlowe AT, et al
    Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/beta-Catenin Activation.
    Cancer Res. 2017;77:4846-4857.
    PubMed     Text format     Abstract available


  98. METZGER E, Stepputtis SS, Strietz J, Preca BT, et al
    KDM4 inhibition targets breast cancer stem-like cells.
    Cancer Res. 2017 Sep 7. pii: canres.1754.2017.
    PubMed     Text format     Abstract available


    August 2017
  99. YANG F, Wei J, Zhang S, Zhang X, et al
    Shrimp miR-S8 suppresses the stemness of human melanoma stem-like cells by targeting the transcription factor YB-1.
    Cancer Res. 2017 Aug 30. pii: canres.1375.2017.
    PubMed     Text format     Abstract available


  100. JIN L, Vu T, Yuan G, Datta PK, et al
    STRAP promotes stemness of human colorectal cancer via epigenetic regulation of the NOTCH pathway.
    Cancer Res. 2017 Aug 21. pii: canres.0286.2017.
    PubMed     Text format     Abstract available


  101. DODD RD, Lee CL, Overton T, Huang W, et al
    NF1+/- Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response.
    Cancer Res. 2017;77:4486-4497.
    PubMed     Text format     Abstract available


  102. ROHIRA AD, Yan F, Wang L, Wang J, et al
    Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells.
    Cancer Res. 2017;77:4293-4304.
    PubMed     Text format     Abstract available


    July 2017
  103. REGGIANI F, Labanca V, Mancuso P, Rabascio C, et al
    Adipose progenitor cell secretion of GM-CSF and MMP9 promotes a stromal and immunological microenvironment that supports breast cancer progression.
    Cancer Res. 2017 Jul 28. pii: canres.0914.2017.
    PubMed     Text format     Abstract available


  104. WANG X, Huang Z, Wu Q, Prager BC, et al
    MYC-regulated Mevalonate Metabolism Maintains Brain Tumor Initiating Cells.
    Cancer Res. 2017 Jul 20. pii: canres.0114.2017.
    PubMed     Text format     Abstract available


    June 2017
  105. HOU PC, Li YH, Lin SC, Lin SC, et al
    Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness.
    Cancer Res. 2017 Jun 26. pii: canres.2990.2016.
    PubMed     Text format     Abstract available


  106. RODRIGUEZ-HERNANDEZ G, Hauer J, Martin-Lorenzo A, Schafer D, et al
    Infection exposure promotes ETV6-RUNX1 precursor B cell leukemia via impaired H3K4 demethylases.
    Cancer Res. 2017 Jun 19. pii: canres.0701.2017.
    PubMed     Text format     Abstract available


    May 2017
  107. YAN H, Romero-Lopez M, Benitez LI, Di K, et al
    3D mathematical modeling of glioblastoma suggests that transdifferentiated vascular endothelial cells mediate resistance to current standard-of-care therapy.
    Cancer Res. 2017 May 23. pii: canres.3094.2016.
    PubMed     Text format     Abstract available


  108. TECH K, Tikunov AP, Farooq H, Morrissy AS, et al
    Pyruvate kinase inhibits proliferation during postnatal cerebellar neurogenesis and suppresses medulloblastoma formation.
    Cancer Res. 2017 May 17. pii: canres.3304.2016.
    PubMed     Text format     Abstract available


  109. RODRIGUEZ-BRENES IA, Kurtova AV, Lin C, Lee YC, et al
    Cellular Hierarchy as a Determinant of Tumor Sensitivity to Chemotherapy.
    Cancer Res. 2017;77:2231-2241.
    PubMed     Text format     Abstract available


    April 2017
  110. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    PubMed     Text format     Abstract available


  111. JARIWALA N, Rajasekaran D, Mendoza RG, Shen XN, et al
    Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.
    Cancer Res. 2017 Apr 20. pii: canres.0298.2017.
    PubMed     Text format     Abstract available


  112. SARKAR S, Mirzaei R, Zemp FJ, Wu W, et al
    Activation of NOTCH signaling by tenascin-C promotes growth of human brain tumor-initiating cells.
    Cancer Res. 2017 Apr 17. pii: canres.2171.2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: